Moderna (MRNA) reported mixed fourth quarter earnings and full-year 2024 earnings Friday. Moderna's stock was down 5% in premarket trading on the earnings results but rose more than 2% sharply after ...

Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

Moderna's (MRNA) fourth-quarter loss came in higher than Wall Street's expectations as its sales fell amid the impact of an early launch of the drugmaker's updated COVID-19 vaccine in the US. The ...

The research focuses on cells’ “feet,” which are small bundles of molecules that help cells move. Scientists are exploring ...

Hedge fund giant Bridgewater Associates placed a new bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron Technology and banking giant Goldman Sachs. The latest 13-F filing ...